These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 28074193)

  • 1. Serum 25-Hydroxyvitamin D3 and BAFF Levels Are Associated with Disease Activity in Primary Sjogren's Syndrome.
    Lee SJ; Oh HJ; Choi BY; Jang YJ; Lee JY; Park JK; Song YW
    J Immunol Res; 2016; 2016():5781070. PubMed ID: 28074193
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum levels of beta2-microglobulin and free light chains of immunoglobulins are associated with systemic disease activity in primary Sjögren's syndrome. Data at enrollment in the prospective ASSESS cohort.
    Gottenberg JE; Seror R; Miceli-Richard C; Benessiano J; Devauchelle-Pensec V; Dieude P; Dubost JJ; Fauchais AL; Goeb V; Hachulla E; Hatron PY; Larroche C; Le Guern V; Morel J; Perdriger A; Puéchal X; Rist S; Saraux A; Sene D; Sibilia J; Vittecoq O; Nocturne G; Ravaud P; Mariette X
    PLoS One; 2013; 8(5):e59868. PubMed ID: 23717383
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serological lymphocytic activity and patient-reported outcomes in Sjögren's syndrome.
    Jülich M; Kanne AM; Sehnert B; Budweiser S; Voll RE; Kollert F
    Clin Rheumatol; 2018 Sep; 37(9):2361-2366. PubMed ID: 29858711
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum CXCL13, BAFF, IL-21 and IL-22 levels are related to disease activity and lymphocyte profile in primary Sjögren's syndrome.
    Loureiro-Amigo J; Franco-Jarava C; Perurena-Prieto J; Palacio C; Martínez-Valle F; Soláns-Laqué R
    Clin Exp Rheumatol; 2021; 39 Suppl 133(6):131-139. PubMed ID: 34919042
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BLyS upregulation in Sjogren's syndrome associated with lymphoproliferative disorders, higher ESSDAI score and B-cell clonal expansion in the salivary glands.
    Quartuccio L; Salvin S; Fabris M; Maset M; Pontarini E; Isola M; De Vita S
    Rheumatology (Oxford); 2013 Feb; 52(2):276-81. PubMed ID: 22879463
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of BAFF and IL-17A with subphenotypes of primary Sjögren's syndrome.
    Deng F; Chen J; Zheng J; Chen Y; Huang R; Yin J; Gao X; Lin Q; Huang C; Gao Y; Yu X; Liu Z
    Int J Rheum Dis; 2016 Jul; 19(7):715-20. PubMed ID: 25941062
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ESSPRI and other patient-reported indices in patients with primary Sjogren's syndrome during 100 consecutive outpatient visits at one rheumatological clinic.
    Pertovaara M; Korpela M
    Rheumatology (Oxford); 2014 May; 53(5):927-31. PubMed ID: 24464708
    [TBL] [Abstract][Full Text] [Related]  

  • 8. B-cell activity markers are associated with different disease activity domains in primary Sjögren's syndrome.
    James K; Chipeta C; Parker A; Harding S; Cockell SJ; Gillespie CS; Hallinan J; Barone F; Bowman SJ; Ng WF; Fisher BA;
    Rheumatology (Oxford); 2018 Jul; 57(7):1222-1227. PubMed ID: 29608774
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum levels of BAFF, but not APRIL, are increased after rituximab treatment in patients with primary Sjogren's syndrome: data from a placebo-controlled clinical trial.
    Pollard RP; Abdulahad WH; Vissink A; Hamza N; Burgerhof JG; Meijer JM; Visser A; Huitema MG; Spijkervet FK; Kallenberg CG; Bootsma H; Kroese FG
    Ann Rheum Dis; 2013 Jan; 72(1):146-8. PubMed ID: 22851468
    [No Abstract]   [Full Text] [Related]  

  • 10. Identification of definitive serum biomarkers associated with disease activity in primary Sjögren's syndrome.
    Nishikawa A; Suzuki K; Kassai Y; Gotou Y; Takiguchi M; Miyazaki T; Yoshimoto K; Yasuoka H; Yamaoka K; Morita R; Yoshimura A; Takeuchi T
    Arthritis Res Ther; 2016 May; 18(1):106. PubMed ID: 27180164
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Salivary and serum B-cell activating factor (BAFF) levels after hydroxychloroquine treatment in primary Sjögren's syndrome.
    Mumcu G; Biçakçigil M; Yilmaz N; Ozay H; Karaçayli U; Cimilli H; Yavuz S
    Oral Health Prev Dent; 2013; 11(3):229-34. PubMed ID: 23878841
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fatigue in Primary Sjögren's Syndrome: Clinical, Laboratory, Psychometric, and Biologic Associations.
    Karageorgas T; Fragioudaki S; Nezos A; Karaiskos D; Moutsopoulos HM; Mavragani CP
    Arthritis Care Res (Hoboken); 2016 Jan; 68(1):123-31. PubMed ID: 26315379
    [TBL] [Abstract][Full Text] [Related]  

  • 13. B-cell activating factor of the tumour necrosis factor family expression in blood monocytes and T cells from patients with primary Sjögren's syndrome.
    Lavie F; Miceli-Richard C; Ittah M; Sellam J; Gottenberg JE; Mariette X
    Scand J Immunol; 2008 Feb; 67(2):185-92. PubMed ID: 18201372
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of High Mobility Group Box Chromosomal Protein 1 and Receptor for Advanced Glycation End Products Serum Concentrations With Extraglandular Involvement and Disease Activity in Sjögren's Syndrome.
    Kanne AM; Jülich M; Mahmutovic A; Tröster I; Sehnert B; Urbonaviciute V; Voll RE; Kollert F
    Arthritis Care Res (Hoboken); 2018 Jun; 70(6):944-948. PubMed ID: 28941024
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [BAFF/APRIL pathway in Sjögren syndrome and systemic lupus erythematosus: relationship with chronic inflammation and disease activity].
    Vadacca M; Margiotta D; Sambataro D; Buzzulini F; Lo Vullo M; Rigon A; Afeltra A
    Reumatismo; 2010; 62(4):259-65. PubMed ID: 21253619
    [TBL] [Abstract][Full Text] [Related]  

  • 16. European League Against Rheumatism Sjögren's Syndrome Disease Activity Index and European League Against Rheumatism Sjögren's Syndrome Patient-Reported Index: a complete picture of primary Sjögren's syndrome patients.
    Seror R; Gottenberg JE; Devauchelle-Pensec V; Dubost JJ; Le Guern V; Hayem G; Fauchais AL; Goeb V; Hachulla E; Hatron PY; Larroche C; Morel J; Pedriger A; Puechal X; Rist S; Saraux A; Sene D; Sibilia J; Vittecoq O; Zarnitsky C; Labetoulle M; Ravaud P; Mariette X
    Arthritis Care Res (Hoboken); 2013 Aug; 65(8):1358-64. PubMed ID: 23436737
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduced 25-hydroxyvitamin D levels in primary Sjögren's syndrome. Correlations to disease manifestations.
    Bang B; Asmussen K; Sørensen OH; Oxholm P
    Scand J Rheumatol; 1999; 28(3):180-3. PubMed ID: 10380841
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is periodontal disease mediated by salivary BAFF in Sjögren's syndrome?
    Pers JO; d'Arbonneau F; Devauchelle-Pensec V; Saraux A; Pennec YL; Youinou P
    Arthritis Rheum; 2005 Aug; 52(8):2411-4. PubMed ID: 16052575
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum beta-2-microglobulin in Sjögren's syndrome.
    Ström T; Evrin PE; Karlsson A
    Scand J Rheumatol; 1978; 7(2):97-100. PubMed ID: 81519
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation of serum B lymphocyte stimulator and beta2 microglobulin with autoantibody secretion and systemic involvement in primary Sjogren's syndrome.
    Gottenberg JE; Busson M; Cohen-Solal J; Lavie F; Abbed K; Kimberly RP; Sibilia J; Mariette X
    Ann Rheum Dis; 2005 Jul; 64(7):1050-5. PubMed ID: 15640273
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.